Something Big Could Happen To NVIDIA Stock on August 26

Ahead of NVIDIA’s Aug. 26 FY Q2 2027 report, management guided Q2 revenue to $91B ±2% and non-GAAP gross margin of 75%, with guidance explicitly excluding Data Center compute revenue from China. The article cites demand “gone parabolic” with full confidence in $1T of Blackwell and Rubin revenue from 2025–2027 and backlog/supply commitments of $119B, alongside heavy capital return: an additional $80B buyback, with the quarterly dividend raised from $0.01 to $0.25 and Q1 FCF of $48.5B. Data Center revenue is highlighted at $75.2B (up 92% YoY) with networking up 199%, making the setup bullish despite the note that NVIDIA shipped zero H20 units to China in Q1.

Analysis

NVDA is still the cleanest near-term beneficiary of AI capex, but the market has moved from debating demand to debating durability. That shifts the trade from "own the beat" to "own the guide": the stock should absorb a modestly good print only if management keeps preserving gross margin and backlog conversion while refraining from any China optimism. The real upside is not the quarter; it is whether the book-to-bill tone validates that hyperscaler capex is becoming a multi-quarter commitment rather than a one-off budget flush.

Relative losers are AMD and, to a lesser extent, AVGO on a momentum basis. AMD is most exposed to the narrative that share gains will arrive later than bulls expect, so any NVDA upside re-prices the timing gap and compresses AMD's scarcity premium. AVGO is better insulated operationally, but if investors re-anchor on NVDA's growth-plus-capital-return profile, AVGO can be de-rated as a slower-growing AI beneficiary with less direct accelerator leverage.

The main risk is not a miss; it is a great print followed by an underwhelming forward posture. In the 1-3 month window, a headline beat with only in-line guidance could trigger profit-taking given positioning and implied-event expectations. Over 6-18 months, the question is whether Blackwell/Rubin ramp keeps outpacing customer digestion; if backlog starts converting more slowly or gross margin slips, the multiple can compress quickly despite buybacks. The consensus may be underestimating how much of the optimism is already in the name; the contrarian signal is to use any post-event pullback as the higher-conviction entry, not chase into the number.

Key Decisions for Investors

• Buy NVDA on any 3-5% post-earnings selloff or hold into Aug. 26 via a defined-risk Sep/Oct call spread; thesis is guide durability, not the headline beat. Falsify if gross margin comes in below ~74.5% or management does not re-affirm multi-quarter demand momentum.
• Relative-value trade: long NVDA / short AMD for the 1-3 month window. AMD is more vulnerable to timing disappointments in AI share gains; risk is a broad AI-capex re-rating that lifts both names.
• For lower-vol exposure, replace outright NVDA equity with a staggered call spread into the report to avoid paying peak implied volatility. Best setup if IV remains elevated into the print.
• If already long AVGO, consider trimming vs. NVDA ahead of earnings. AVGO can still benefit from AI spend, but NVDA has the cleaner growth-to-capital-return combo and may keep taking relative share of investor flow.
• Set a post-print alert on NVDA margin commentary and China commentary; if guidance excludes less than expected or margin guide slips, treat it as a signal to de-risk rather than add.